NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|71986891|ref|NP_494531|]
View 

Neprilysin [Caenorhabditis elegans]

Protein Classification

gluzincin family metallopeptidase( domain architecture ID 55759)

gluzincin family metallopeptidase is a zinc-dependent peptidase that contains an HEXXH motif as part of its active site; it binds a single catalytic zinc ion which is tetrahedrally coordinated by three amino acid ligands and a water molecule that forms the nucleophile upon activation during catalysis

Gene Ontology:  GO:0008237|GO:0008270
PubMed:  7674922
SCOP:  3001975

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
GluZincin super family cl14813
Gluzincin Peptidase family (thermolysin-like proteinases, TLPs) which includes peptidases M1, ...
87-698 6.00e-67

Gluzincin Peptidase family (thermolysin-like proteinases, TLPs) which includes peptidases M1, M2, M3, M4, M13, M32 and M36 (fungalysins); The Gluzincin family (thermolysin-like peptidases or TLPs) includes several zinc-dependent metallopeptidases such as M1, M2, M3, M4, M13, M32, M36 peptidases (MEROPS classification), which contain the HEXXH motif as part of their active site. Peptidases in this family bind a single catalytic zinc ion which is tetrahedrally co-ordinated by three amino acid ligands and a water molecule that forms the nucleophile on activation during catalysis. The M1 family includes aminopeptidase N (APN) and leukotriene A4 hydrolase (LTA4H). APN preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and is present in a variety of human tissues and cell types. LTA4H is a bifunctional enzyme, possessing an aminopeptidase as well as an epoxide hydrolase activity such that the two activities occupy different, but overlapping sites. The M3_like peptidases include the M2_ACE, M3 or neurolysin-like family (subfamilies M3B_PepF and M3A) and M32_Taq peptidases. The M2 peptidase angiotensin converting enzyme (ACE, EC 3.4.15.1) catalyzes the conversion of decapeptide angiotensin I to the potent vasopressor octapeptide angiotensin II. ACE is a key component of the renin-angiotensin system that regulates blood pressure, thus ACE inhibitors are important for the treatment of hypertension. M3A includes thimet oligopeptidase (TOP; endopeptidase 3.4.24.15), neurolysin (3.4.24.16), and the mitochondrial intermediate peptidase; and M3B includes oligopeptidase F. The M32 family includes eukaryotic enzymes from protozoa Trypanosoma cruzi, a causative agent of Chagas' disease, and from Leishmania major, a parasite that causes leishmaniasis, making these enzymes attractive targets for drug development. The M4 family includes secreted protease thermolysin (EC 3.4.24.27), pseudolysin, aureolysin, and neutral protease as well as bacillolysin (EC 3.4.24.28) that degrade extracellular proteins and peptides for bacterial nutrition, especially prior to sporulation. Thermolysin is widely used as a nonspecific protease to obtain fragments for peptide sequencing as well as in production of the artificial sweetener aspartame. The M13 family includes neprilysin (EC 3.4.24.11) and endothelin-converting enzyme I (ECE-1, EC 3.4.24.71), which fulfill a broad range of physiological roles due to the greater variation in the S2' subsite allowing substrate specificity and are prime therapeutic targets for selective inhibition. The peptidase M36 fungalysin family includes endopeptidases from pathogenic fungi. Fungalysin hydrolyzes extracellular matrix proteins such as elastin and keratin. Aspergillus fumigatus causes the pulmonary disease aspergillosis by invading the lungs of immuno-compromised animals and secreting fungalysin that possibly breaks down proteinaceous structural barriers.


The actual alignment was detected with superfamily member cd08662:

Pssm-ID: 472708 [Multi-domain]  Cd Length: 642  Bit Score: 232.26  E-value: 6.00e-67
                        10        20        30        40        50        60        70        80
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 71986891  87 CEDFYKATCENYKDHQALDRHRDC-----KKRKAVNKLVRGFLQRDESTFT-SESESAIKLIFGKC-DELSRNTSYLD-I 158
Cdd:cd08662   4 CDDFYQYACGNWLKNHPIPADKSSwgsfsELQDRNEEQLREILEEAASSAAdSSAEQKAKDFYKSCmDEEAIEKLGLKpL 83
                        90       100       110       120       130       140       150       160
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 71986891 159 FKDIKKIGSWPVLEHNWKDSMFNLDDVIAKLVKLG---STDFG-----LFKLELRKLAFGHFAVFVSSKQEQNIHQLEKT 230
Cdd:cd08662  84 KPLLDKIGGLPSLDDLAAELLLALLRRLGVSLLFGlgvSPDPKnssrnILYLGQPGLGLPDRDYYLDEENAEIREAYKKY 163
                       170       180       190       200       210       220       230       240
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 71986891 231 ILGILKANGIqqDRKELSDDLKDYSDFKNHLKEFY--QEETYIEYRLYagSIVENLGISSLTTQMALKS--TGLDVFNHV 306
Cdd:cd08662 164 IAKLLELLGA--DEEEAEKLAEDVLAFETELAKISlsSEELRDPEKTY--NPLTLAELQKLAPSIDWKAylKALGPPADD 239
                       250       260       270       280       290       300       310       320
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 71986891 307 NQRTLITNSSLFfgeeNNLGMIIQKTPKRTLANFLIFHFIDVMTTDLANAT---------------------KACKETLI 365
Cdd:cd08662 240 PDKVIVSQPEYL----KKLDKLLASTPLRTLKNYLIWRLLDSLAPYLSKEFrdarffygkalsgqkepeprwKRCVELVN 315
                       330       340       350       360       370       380       390       400
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 71986891 366 DLLPRASIQVLSRNFVNEDAQDDMVKMAQDLKTKITEMIDNSPFFtkfhlvfDAEEQKKLIQKVKAIGIVTEYPQEVLDR 445
Cdd:cd08662 316 GALGEALGRLYVEKYFSEEAKADVEEMVENIKEAFKERLENLDWM-------DEETKKKALEKLDAMKVKIGYPDKWRDY 388
                       410       420       430       440       450       460       470       480
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 71986891 446 ---DFERLNLTPSDSIYRTIQKLRRLRSEQLIEHLGGDLDPTDtrvWGS------AHYDQTTNNLTIFAPIIDGPYFDTS 516
Cdd:cd08662 389 salDIYYDDLNVSDSYFENVLRLLRFETKRQLAKLGKPVDRTE---WSMspqtvnAYYNPSLNEIVFPAGILQPPFFDPD 465
                       490       500       510       520       530       540       550       560
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 71986891 517 YPNYVNqF-LMGFILGRELGRSLDSVRIRKDEKGQTENWLKPESLKRFDEHLKCWAEKYDKSADPLKseskgiRQIEGRY 595
Cdd:cd08662 466 APDALN-YgGIGAVIGHEITHGFDDQGRQYDENGNLRNWWTNEDRKEFEERAQCLVDQYSNYEVPPG------LHVNGKL 538
                       570       580       590       600       610       620       630       640
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 71986891 596 IQNEMFADFIGHEASWRAFMKLDVKNEEVLETFKVIKLRRMFFNVQALYFCRPPS-GSTDWLSYQEHHQHYSFRVNGAFK 674
Cdd:cd08662 539 TLGENIADNGGLRLAYRAYKKWLKENGPELPGLEGFTPEQLFFLSFAQVWCSKYRpEALRQLLLTDPHSPGKFRVNGPLS 618
                       650       660
                ....*....|....*....|....
gi 71986891 675 NMPQFALAFECASDDDMNPQNKCS 698
Cdd:cd08662 619 NSPEFAEAFNCPPGSPMNPEKKCR 642
 
Name Accession Description Interval E-value
M13 cd08662
Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of ...
87-698 6.00e-67

Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of metallopeptidases includes neprilysin (neutral endopeptidase, NEP, enkephalinase, CD10, CALLA, EC 3.4.24.11), endothelin-converting enzyme I (ECE-1, EC 3.4.24.71), erythrocyte surface antigen KELL (ECE-3), phosphate-regulating gene on the X chromosome (PHEX), soluble secreted endopeptidase (SEP), and damage-induced neuronal endopeptidase (DINE)/X-converting enzyme (XCE). Proteins in this family fulfill a broad range of physiological roles due to the greater variation in the active site's S2' subsite allowing substrate specificity. NEP is expressed in a variety of tissues including kidney and brain, and is involved in many physiological and pathological processes, including blood pressure and inflammatory response. It degrades a wide array of substrates such as substance P, enkephalins, cholecystokinin, neurotensin and somatostatin. It is an important enzyme in the regulation of amyloid-beta (Abeta) protein that forms amyloid plaques that are associated with Alzeimers disease (AD). ECE-1 catalyzes the final rate-limiting step in the biosynthesis of endothelins via post-translational conversion of the biologically inactive big endothelins. Like NEP, it also hydrolyzes bradykinin, substance P, neurotensin, and Abeta. Endothelin-1 overproduction has been implicated in various diseases including stroke, asthma, hypertension, and cardiac and renal failure. Kell is a homolog of NEP and constitutes a major antigen on human erythrocytes; it preferentially cleaves big endothelin-3 to produce bioactive endothelin-3, but is also known to cleave substance P and neurokinin A. PHEX forms a complex interaction with fibroblast growth factor 23 (FGF23) and matrix extracellular phosphoglycoprotein, causing bone mineralization. A loss-of-function mutation in PHEX disrupts this interaction leading to hypophosphatemic rickets; X-linked hypophosphatemic (XLH) rickets is the most common form of metabolic rickets. ECEL1 is a brain metalloprotease which plays a critical role in the nervous regulation of the respiratory system, while DINE is abundantly expressed in the hypothalamus and its expression responds to nerve injury. A majority of these M13 proteases are prime therapeutic targets for selective inhibition.


Pssm-ID: 341056 [Multi-domain]  Cd Length: 642  Bit Score: 232.26  E-value: 6.00e-67
                        10        20        30        40        50        60        70        80
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 71986891  87 CEDFYKATCENYKDHQALDRHRDC-----KKRKAVNKLVRGFLQRDESTFT-SESESAIKLIFGKC-DELSRNTSYLD-I 158
Cdd:cd08662   4 CDDFYQYACGNWLKNHPIPADKSSwgsfsELQDRNEEQLREILEEAASSAAdSSAEQKAKDFYKSCmDEEAIEKLGLKpL 83
                        90       100       110       120       130       140       150       160
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 71986891 159 FKDIKKIGSWPVLEHNWKDSMFNLDDVIAKLVKLG---STDFG-----LFKLELRKLAFGHFAVFVSSKQEQNIHQLEKT 230
Cdd:cd08662  84 KPLLDKIGGLPSLDDLAAELLLALLRRLGVSLLFGlgvSPDPKnssrnILYLGQPGLGLPDRDYYLDEENAEIREAYKKY 163
                       170       180       190       200       210       220       230       240
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 71986891 231 ILGILKANGIqqDRKELSDDLKDYSDFKNHLKEFY--QEETYIEYRLYagSIVENLGISSLTTQMALKS--TGLDVFNHV 306
Cdd:cd08662 164 IAKLLELLGA--DEEEAEKLAEDVLAFETELAKISlsSEELRDPEKTY--NPLTLAELQKLAPSIDWKAylKALGPPADD 239
                       250       260       270       280       290       300       310       320
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 71986891 307 NQRTLITNSSLFfgeeNNLGMIIQKTPKRTLANFLIFHFIDVMTTDLANAT---------------------KACKETLI 365
Cdd:cd08662 240 PDKVIVSQPEYL----KKLDKLLASTPLRTLKNYLIWRLLDSLAPYLSKEFrdarffygkalsgqkepeprwKRCVELVN 315
                       330       340       350       360       370       380       390       400
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 71986891 366 DLLPRASIQVLSRNFVNEDAQDDMVKMAQDLKTKITEMIDNSPFFtkfhlvfDAEEQKKLIQKVKAIGIVTEYPQEVLDR 445
Cdd:cd08662 316 GALGEALGRLYVEKYFSEEAKADVEEMVENIKEAFKERLENLDWM-------DEETKKKALEKLDAMKVKIGYPDKWRDY 388
                       410       420       430       440       450       460       470       480
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 71986891 446 ---DFERLNLTPSDSIYRTIQKLRRLRSEQLIEHLGGDLDPTDtrvWGS------AHYDQTTNNLTIFAPIIDGPYFDTS 516
Cdd:cd08662 389 salDIYYDDLNVSDSYFENVLRLLRFETKRQLAKLGKPVDRTE---WSMspqtvnAYYNPSLNEIVFPAGILQPPFFDPD 465
                       490       500       510       520       530       540       550       560
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 71986891 517 YPNYVNqF-LMGFILGRELGRSLDSVRIRKDEKGQTENWLKPESLKRFDEHLKCWAEKYDKSADPLKseskgiRQIEGRY 595
Cdd:cd08662 466 APDALN-YgGIGAVIGHEITHGFDDQGRQYDENGNLRNWWTNEDRKEFEERAQCLVDQYSNYEVPPG------LHVNGKL 538
                       570       580       590       600       610       620       630       640
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 71986891 596 IQNEMFADFIGHEASWRAFMKLDVKNEEVLETFKVIKLRRMFFNVQALYFCRPPS-GSTDWLSYQEHHQHYSFRVNGAFK 674
Cdd:cd08662 539 TLGENIADNGGLRLAYRAYKKWLKENGPELPGLEGFTPEQLFFLSFAQVWCSKYRpEALRQLLLTDPHSPGKFRVNGPLS 618
                       650       660
                ....*....|....*....|....
gi 71986891 675 NMPQFALAFECASDDDMNPQNKCS 698
Cdd:cd08662 619 NSPEFAEAFNCPPGSPMNPEKKCR 642
Peptidase_M13 pfam01431
Peptidase family M13; Mammalian enzymes are typically type-II membrane anchored enzymes which ...
492-698 9.36e-41

Peptidase family M13; Mammalian enzymes are typically type-II membrane anchored enzymes which are known, or believed to activate or inactivate oligopeptide (pro)-hormones such as opioid peptides. The family also contains a bacterial member believed to be involved with milk protein cleavage.


Pssm-ID: 279739 [Multi-domain]  Cd Length: 205  Bit Score: 147.95  E-value: 9.36e-41
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 71986891   492 AHYDQTTNNLTIFAPIIDGPYFDTSYPNYVNQFLMGFILGRELGRSLDSVRIRKDEKGQTENWLKPESLKRFDEHLKCWA 571
Cdd:pfam01431   2 AYYQPNRNEIVFPAAILQPPFFDPNYPRAVNYGGIGNVIAHEITHGFDDQGAQFDKDGNLRSWWTDEDAEEFKDRAQCLI 81
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 71986891   572 EKYDKSADPlksesKGIRQIEGRYIQNEMFADFIGHEASWRAFMKLDVKNEEVLETFKVIKLRRMFFNVQALYFCRPPSG 651
Cdd:pfam01431  82 EQYSEYTPP-----DGTKCANGTLTLGENIADLGGLTIALRAYKKLLSANETVLPGFENLTPDQLFFRGAAQIWCMKQSP 156
                         170       180       190       200
                  ....*....|....*....|....*....|....*....|....*...
gi 71986891   652 STD-WLSYQEHHQHYSFRVNGAFKNMPQFALAFECASDDDMNPQNKCS 698
Cdd:pfam01431 157 AEVlRQLLVDPHSPPEFRVNGVMSNMPAFYEAFNCPEGDKMNPEPRCR 204
PepO COG3590
Predicted metalloendopeptidase [Posttranslational modification, protein turnover, chaperones];
378-691 7.87e-11

Predicted metalloendopeptidase [Posttranslational modification, protein turnover, chaperones];


Pssm-ID: 442809 [Multi-domain]  Cd Length: 674  Bit Score: 65.17  E-value: 7.87e-11
                        10        20        30        40        50        60        70        80
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 71986891 378 RNFvNEDAQDDMVKMAQDLKTKITEMIDNSPFFTkfhlvfdAEEQKKLIQKVKA----IGivteYPQEvlDRDFERLNLT 453
Cdd:COG3590 365 RYF-PPEAKARMEELVANLRAAYRERIENLDWMS-------PETKAKALEKLAAftpkIG----YPDK--WRDYSGLEIK 430
                        90       100       110       120       130       140       150       160
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 71986891 454 PsDSIYRTIQKLRRLRSEQLIEHLGGdldPTDTRVWG------SAHYDQTTNNLTIFAPIIDGPYFDTSYPNYVNQFLMG 527
Cdd:COG3590 431 R-DDLVGNVLRASAFEYQRELAKLGK---PVDRTEWGmtpqtvNAYYNPTMNEIVFPAAILQPPFFDPKADDAVNYGGIG 506
                       170       180       190       200       210       220       230       240
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 71986891 528 FILGRELGRSLDSVRIRKDEKGQTENWLKPESLKRFDEHLKCWAEKYDkSADPLKSEskgirQIEGRYIQNEMFADFIGH 607
Cdd:COG3590 507 AVIGHEITHGFDDQGSQFDGDGNLRNWWTPEDRAAFEARTKKLVAQYD-AYEPLPGL-----HVNGKLTLGENIADLGGL 580
                       250       260       270       280       290       300       310       320
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 71986891 608 EASWRAFMK-LDVKNEEVLETFKviKLRRMFFN------VQAlyfcRPPSG----STDwlsyqEHhqhyS---FRVNGAF 673
Cdd:COG3590 581 SIAYDAYKLsLKGKEAPVIDGFT--GDQRFFLGwaqvwrSKA----RDEALrqrlATD-----PH----SpgeFRVNGPV 645
                       330
                ....*....|....*...
gi 71986891 674 KNMPQFALAFECASDDDM 691
Cdd:COG3590 646 RNLDAFYEAFDVKPGDKM 663
 
Name Accession Description Interval E-value
M13 cd08662
Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of ...
87-698 6.00e-67

Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of metallopeptidases includes neprilysin (neutral endopeptidase, NEP, enkephalinase, CD10, CALLA, EC 3.4.24.11), endothelin-converting enzyme I (ECE-1, EC 3.4.24.71), erythrocyte surface antigen KELL (ECE-3), phosphate-regulating gene on the X chromosome (PHEX), soluble secreted endopeptidase (SEP), and damage-induced neuronal endopeptidase (DINE)/X-converting enzyme (XCE). Proteins in this family fulfill a broad range of physiological roles due to the greater variation in the active site's S2' subsite allowing substrate specificity. NEP is expressed in a variety of tissues including kidney and brain, and is involved in many physiological and pathological processes, including blood pressure and inflammatory response. It degrades a wide array of substrates such as substance P, enkephalins, cholecystokinin, neurotensin and somatostatin. It is an important enzyme in the regulation of amyloid-beta (Abeta) protein that forms amyloid plaques that are associated with Alzeimers disease (AD). ECE-1 catalyzes the final rate-limiting step in the biosynthesis of endothelins via post-translational conversion of the biologically inactive big endothelins. Like NEP, it also hydrolyzes bradykinin, substance P, neurotensin, and Abeta. Endothelin-1 overproduction has been implicated in various diseases including stroke, asthma, hypertension, and cardiac and renal failure. Kell is a homolog of NEP and constitutes a major antigen on human erythrocytes; it preferentially cleaves big endothelin-3 to produce bioactive endothelin-3, but is also known to cleave substance P and neurokinin A. PHEX forms a complex interaction with fibroblast growth factor 23 (FGF23) and matrix extracellular phosphoglycoprotein, causing bone mineralization. A loss-of-function mutation in PHEX disrupts this interaction leading to hypophosphatemic rickets; X-linked hypophosphatemic (XLH) rickets is the most common form of metabolic rickets. ECEL1 is a brain metalloprotease which plays a critical role in the nervous regulation of the respiratory system, while DINE is abundantly expressed in the hypothalamus and its expression responds to nerve injury. A majority of these M13 proteases are prime therapeutic targets for selective inhibition.


Pssm-ID: 341056 [Multi-domain]  Cd Length: 642  Bit Score: 232.26  E-value: 6.00e-67
                        10        20        30        40        50        60        70        80
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 71986891  87 CEDFYKATCENYKDHQALDRHRDC-----KKRKAVNKLVRGFLQRDESTFT-SESESAIKLIFGKC-DELSRNTSYLD-I 158
Cdd:cd08662   4 CDDFYQYACGNWLKNHPIPADKSSwgsfsELQDRNEEQLREILEEAASSAAdSSAEQKAKDFYKSCmDEEAIEKLGLKpL 83
                        90       100       110       120       130       140       150       160
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 71986891 159 FKDIKKIGSWPVLEHNWKDSMFNLDDVIAKLVKLG---STDFG-----LFKLELRKLAFGHFAVFVSSKQEQNIHQLEKT 230
Cdd:cd08662  84 KPLLDKIGGLPSLDDLAAELLLALLRRLGVSLLFGlgvSPDPKnssrnILYLGQPGLGLPDRDYYLDEENAEIREAYKKY 163
                       170       180       190       200       210       220       230       240
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 71986891 231 ILGILKANGIqqDRKELSDDLKDYSDFKNHLKEFY--QEETYIEYRLYagSIVENLGISSLTTQMALKS--TGLDVFNHV 306
Cdd:cd08662 164 IAKLLELLGA--DEEEAEKLAEDVLAFETELAKISlsSEELRDPEKTY--NPLTLAELQKLAPSIDWKAylKALGPPADD 239
                       250       260       270       280       290       300       310       320
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 71986891 307 NQRTLITNSSLFfgeeNNLGMIIQKTPKRTLANFLIFHFIDVMTTDLANAT---------------------KACKETLI 365
Cdd:cd08662 240 PDKVIVSQPEYL----KKLDKLLASTPLRTLKNYLIWRLLDSLAPYLSKEFrdarffygkalsgqkepeprwKRCVELVN 315
                       330       340       350       360       370       380       390       400
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 71986891 366 DLLPRASIQVLSRNFVNEDAQDDMVKMAQDLKTKITEMIDNSPFFtkfhlvfDAEEQKKLIQKVKAIGIVTEYPQEVLDR 445
Cdd:cd08662 316 GALGEALGRLYVEKYFSEEAKADVEEMVENIKEAFKERLENLDWM-------DEETKKKALEKLDAMKVKIGYPDKWRDY 388
                       410       420       430       440       450       460       470       480
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 71986891 446 ---DFERLNLTPSDSIYRTIQKLRRLRSEQLIEHLGGDLDPTDtrvWGS------AHYDQTTNNLTIFAPIIDGPYFDTS 516
Cdd:cd08662 389 salDIYYDDLNVSDSYFENVLRLLRFETKRQLAKLGKPVDRTE---WSMspqtvnAYYNPSLNEIVFPAGILQPPFFDPD 465
                       490       500       510       520       530       540       550       560
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 71986891 517 YPNYVNqF-LMGFILGRELGRSLDSVRIRKDEKGQTENWLKPESLKRFDEHLKCWAEKYDKSADPLKseskgiRQIEGRY 595
Cdd:cd08662 466 APDALN-YgGIGAVIGHEITHGFDDQGRQYDENGNLRNWWTNEDRKEFEERAQCLVDQYSNYEVPPG------LHVNGKL 538
                       570       580       590       600       610       620       630       640
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 71986891 596 IQNEMFADFIGHEASWRAFMKLDVKNEEVLETFKVIKLRRMFFNVQALYFCRPPS-GSTDWLSYQEHHQHYSFRVNGAFK 674
Cdd:cd08662 539 TLGENIADNGGLRLAYRAYKKWLKENGPELPGLEGFTPEQLFFLSFAQVWCSKYRpEALRQLLLTDPHSPGKFRVNGPLS 618
                       650       660
                ....*....|....*....|....
gi 71986891 675 NMPQFALAFECASDDDMNPQNKCS 698
Cdd:cd08662 619 NSPEFAEAFNCPPGSPMNPEKKCR 642
Peptidase_M13 pfam01431
Peptidase family M13; Mammalian enzymes are typically type-II membrane anchored enzymes which ...
492-698 9.36e-41

Peptidase family M13; Mammalian enzymes are typically type-II membrane anchored enzymes which are known, or believed to activate or inactivate oligopeptide (pro)-hormones such as opioid peptides. The family also contains a bacterial member believed to be involved with milk protein cleavage.


Pssm-ID: 279739 [Multi-domain]  Cd Length: 205  Bit Score: 147.95  E-value: 9.36e-41
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 71986891   492 AHYDQTTNNLTIFAPIIDGPYFDTSYPNYVNQFLMGFILGRELGRSLDSVRIRKDEKGQTENWLKPESLKRFDEHLKCWA 571
Cdd:pfam01431   2 AYYQPNRNEIVFPAAILQPPFFDPNYPRAVNYGGIGNVIAHEITHGFDDQGAQFDKDGNLRSWWTDEDAEEFKDRAQCLI 81
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 71986891   572 EKYDKSADPlksesKGIRQIEGRYIQNEMFADFIGHEASWRAFMKLDVKNEEVLETFKVIKLRRMFFNVQALYFCRPPSG 651
Cdd:pfam01431  82 EQYSEYTPP-----DGTKCANGTLTLGENIADLGGLTIALRAYKKLLSANETVLPGFENLTPDQLFFRGAAQIWCMKQSP 156
                         170       180       190       200
                  ....*....|....*....|....*....|....*....|....*...
gi 71986891   652 STD-WLSYQEHHQHYSFRVNGAFKNMPQFALAFECASDDDMNPQNKCS 698
Cdd:pfam01431 157 AEVlRQLLVDPHSPPEFRVNGVMSNMPAFYEAFNCPEGDKMNPEPRCR 204
PepO COG3590
Predicted metalloendopeptidase [Posttranslational modification, protein turnover, chaperones];
378-691 7.87e-11

Predicted metalloendopeptidase [Posttranslational modification, protein turnover, chaperones];


Pssm-ID: 442809 [Multi-domain]  Cd Length: 674  Bit Score: 65.17  E-value: 7.87e-11
                        10        20        30        40        50        60        70        80
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 71986891 378 RNFvNEDAQDDMVKMAQDLKTKITEMIDNSPFFTkfhlvfdAEEQKKLIQKVKA----IGivteYPQEvlDRDFERLNLT 453
Cdd:COG3590 365 RYF-PPEAKARMEELVANLRAAYRERIENLDWMS-------PETKAKALEKLAAftpkIG----YPDK--WRDYSGLEIK 430
                        90       100       110       120       130       140       150       160
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 71986891 454 PsDSIYRTIQKLRRLRSEQLIEHLGGdldPTDTRVWG------SAHYDQTTNNLTIFAPIIDGPYFDTSYPNYVNQFLMG 527
Cdd:COG3590 431 R-DDLVGNVLRASAFEYQRELAKLGK---PVDRTEWGmtpqtvNAYYNPTMNEIVFPAAILQPPFFDPKADDAVNYGGIG 506
                       170       180       190       200       210       220       230       240
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 71986891 528 FILGRELGRSLDSVRIRKDEKGQTENWLKPESLKRFDEHLKCWAEKYDkSADPLKSEskgirQIEGRYIQNEMFADFIGH 607
Cdd:COG3590 507 AVIGHEITHGFDDQGSQFDGDGNLRNWWTPEDRAAFEARTKKLVAQYD-AYEPLPGL-----HVNGKLTLGENIADLGGL 580
                       250       260       270       280       290       300       310       320
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 71986891 608 EASWRAFMK-LDVKNEEVLETFKviKLRRMFFN------VQAlyfcRPPSG----STDwlsyqEHhqhyS---FRVNGAF 673
Cdd:COG3590 581 SIAYDAYKLsLKGKEAPVIDGFT--GDQRFFLGwaqvwrSKA----RDEALrqrlATD-----PH----SpgeFRVNGPV 645
                       330
                ....*....|....*...
gi 71986891 674 KNMPQFALAFECASDDDM 691
Cdd:COG3590 646 RNLDAFYEAFDVKPGDKM 663
Peptidase_M13_N pfam05649
Peptidase family M13; M13 peptidases are well-studied proteases found in a wide range of ...
87-439 1.40e-09

Peptidase family M13; M13 peptidases are well-studied proteases found in a wide range of organizms including mammals and bacteria. In mammals they participate in processes such as cardiovascular development, blood-pressure regulation, nervous control of respiration, and regulation of the function of neuropeptides in the central nervous system. In bacteria they may be used for digestion of milk.


Pssm-ID: 461703  Cd Length: 382  Bit Score: 60.39  E-value: 1.40e-09
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 71986891    87 CEDFYKATCENYKDHQAL--DRHRDC---KKRKAVNKLVRGFLQR-DESTFTSESESAIKLIFGKC-DELSRNTSYLD-I 158
Cdd:pfam05649   2 CDDFYQYACGGWLKNHPIpaDKSSWGtfdELRERNEKQLREILEEaAASESDPGAVEKAKDLYKSCmDTDAIEKLGLKpL 81
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 71986891   159 FKDIKKIGSWPvlehnWKDSMFNLDDVIAKLVKLG-STDFGLF-------------KLELRKLAFGHFAVFVSSKQEQNI 224
Cdd:pfam05649  82 KPLLDEIGGPL-----ANKDKFDLLETLAKLRRYGvDSLFGFGvgpddknssrnilYLDQPGLGLPDRDYYLKDRDEKSA 156
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 71986891   225 HQLE---KTILGILKANGIQQDRKELSDDLKDysdfknhlkefyqeetyIEYRLYAGSI--VENLGISSLTTQMALK--- 296
Cdd:pfam05649 157 EIREaykAYIAKLLTLLGASEEAAALAEEVLA-----------------FETKLAKASLsrEERRDPEKTYNPMTLAelq 219
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 71986891   297 --STGLD--------VFNHVNQRTLITNSSLFFgeeNNLGMIIQKTPKRTLANFLIFHFID----VMTTDLANATKACKE 362
Cdd:pfam05649 220 klAPGIDwkaylnaaGLPDVPSDEVIVSQPEYL---KALSKLLAETPLRTLKNYLIWRLVRslapYLSDEFRDANFEFYG 296
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 71986891   363 TL--IDLLPR----ASI------QVLSRNFV----NEDAQDDMVKMAQDLKTKITEMIDNSPFftkfhlvFDAEEQKKLI 426
Cdd:pfam05649 297 TLsgTKQRPRwkrcVSLvngllgEALGRLYVkkyfPEEAKARVEELVENIKEAFRERLDELDW-------MDEETKKKAL 369
                         410
                  ....*....|...
gi 71986891   427 QKVKAIGIVTEYP 439
Cdd:pfam05649 370 EKLDAMTVKIGYP 382
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH